Patients with hard-to-treat tumours could know within six months whether a cancer drug developed at UNSW is more effective than traditional chemotherapy, allowing them to live a relatively normal life during treatment.
If properly designed, the proposed $20 billion Medical Research Future Fund would keep talented researchers in Australia and help bolster exactly the kind of high-tech clever manufacturing industries we need, writes Phil Hogg.
